| Metric | Q3 2020 | Q2 2020 | Q3 2019 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $68M | $52M | — | 32.2% | — |
| Op. Income | $7M | $11M | — | -34.8% | — |
| Gross Margin | 15.8% | 29.8% | — | -14.0pp | — |
| Net Margin | 7.3% | 18.8% | — | -11.5pp | — |
| EPS (Diluted) | $0.16 | $0.31 | — | -47.6% | — |
| Free Cash Flow | -$16M | $6M | — | -360.0% | — |
| Item | Amount |
|---|---|
| REVENUE | $68M |
| Cost of Revenue | $58M |
| GROSS PROFIT | $11M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $4M |
| SG&A Expenses | $4M |
| Other Expenses | -$141.0K |
| Operating Expenses | $4M |
| Cost & Expenses | $61M |
| OPERATING INCOME | $7M |
| Interest Expense | $2M |
| Other Income/Expenses | $926.6K |
| INCOME BEFORE TAX | $8M |
| Income Tax Expense | $3M |
| Net Income from Continuing Ops | $5M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $5M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $5M |
| D&A | $14M |
| EBIT | $11M |
| EBITDA | $25M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $68M |
| Cost of Revenue | $58M |
| GROSS PROFIT | $11M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $4M |
| SG&A Expenses | $4M |
| Other Expenses | -$141.0K |
| Operating Expenses | $4M |
| Cost & Expenses | $61M |
| OPERATING INCOME | $7M |
| Interest Expense | $2M |
| Other Income/Expenses | $926.6K |
| INCOME BEFORE TAX | $8M |
| Income Tax Expense | $3M |
| Net Income from Continuing Ops | $5M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $5M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $5M |
| D&A | $14M |
| EBIT | $11M |
| EBITDA | $25M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $5M |
| Depreciation & Amortization | $14M |
| Stock-Based Compensation | $1M |
| Deferred Income Tax | $3M |
| Other Non-Cash Items | -$4M |
| Change in Working Capital | -$18M |
| OPERATING CASH FLOW | $1M |
| Capital Expenditure | -$17M |
| Acquisitions (Net) | -$123.5K |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $1M |
| NET CASH FROM INVESTING | -$16M |
| Net Debt Issuance | $17M |
| Common Stock Repurchased | -$2M |
| Common Dividends Paid | -$849.2K |
| Other Financing Activities | $8.8K |
| NET CASH FROM FINANCING | $14M |
| FREE CASH FLOW | -$16M |
| Net Change in Cash | -$729.3K |
| Item | Amount |
|---|---|
| Cash & Equivalents | $29M |
| Short-Term Investments | $0 |
| Net Receivables | $36M |
| Inventory | $15M |
| Other Current Assets | $3M |
| TOTAL CURRENT ASSETS | $87M |
| PP&E (Net) | $477M |
| Goodwill | $0 |
| Intangible Assets | $0 |
| Long-Term Investments | $37M |
| Tax Assets | $10M |
| Other Non-Current Assets | $6M |
| TOTAL NON-CURRENT ASSETS | $530M |
| TOTAL ASSETS | $617M |
| Account Payables | $25M |
| Short-Term Debt | $12M |
| Deferred Revenue | $89.2K |
| Other Current Liabilities | $0 |
| TOTAL CURRENT LIABILITIES | $71M |
| Long-Term Debt | $267M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $45M |
| Other Non-Current Liabilities | $13M |
| TOTAL NON-CURRENT LIABILITIES | $371M |
| TOTAL LIABILITIES | $443M |
| Common Stock | $186M |
| Additional Paid-In Capital | $33M |
| Retained Earnings | -$32M |
| Treasury Stock | -$13M |
| Accum. Other Comp. Income | $0 |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $174M |
| Minority Interest | $0 |
| TOTAL EQUITY | $174M |
| TOTAL LIABILITIES & EQUITY | $617M |
| Total Debt | $350M |
| Net Debt | $321M |
